Oppenheimer Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-31,627
| Closed | -$2.51M | – | 1186 |
|
|
2022
Q3 | $2.51M | Sell |
31,627
-8
| -0% | -$635 | 0.04% | 400 |
|
|
2022
Q2 | $2.35M | Buy |
31,635
+3
| +0% | +$223 | 0.04% | 424 |
|
|
2022
Q1 | $2.84M | Sell |
31,632
-4,545
| -13% | -$408K | 0.04% | 427 |
|
|
2021
Q4 | $4.05M | Sell |
36,177
-576
| -2% | -$64.5K | 0.05% | 348 |
|
|
2021
Q3 | $4.62M | Buy |
36,753
+3,329
| +10% | +$419K | 0.07% | 317 |
|
|
2021
Q2 | $4.53M | Buy |
33,424
+848
| +3% | +$115K | 0.06% | 319 |
|
|
2021
Q1 | $4.42M | Buy |
32,576
+658
| +2% | +$89.3K | 0.07% | 309 |
|
|
2020
Q4 | $4.49M | Sell |
31,918
-1,414
| -4% | -$199K | 0.08% | 293 |
|
|
2020
Q3 | $3.71M | Buy |
33,332
+28,531
| +594% | +$3.18M | 0.07% | 299 |
|
|
2020
Q2 | $537K | Sell |
4,801
-432
| -8% | -$48.3K | 0.01% | 784 |
|
|
2020
Q1 | $405K | Sell |
5,233
-315
| -6% | -$24.4K | 0.01% | 795 |
|
|
2019
Q4 | $528K | Sell |
5,548
-75
| -1% | -$7.14K | 0.01% | 803 |
|
|
2019
Q3 | $429K | Sell |
5,623
-297
| -5% | -$22.7K | 0.01% | 845 |
|
|
2019
Q2 | $519K | Sell |
5,920
-366
| -6% | -$32.1K | 0.01% | 804 |
|
|
2019
Q1 | $569K | Sell |
6,286
-410
| -6% | -$37.1K | 0.01% | 764 |
|
|
2018
Q4 | $480K | Sell |
6,696
-281
| -4% | -$20.1K | 0.01% | 778 |
|
|
2018
Q3 | $669K | Sell |
6,977
-192
| -3% | -$18.4K | 0.01% | 726 |
|
|
2018
Q2 | $682K | Sell |
7,169
-105
| -1% | -$9.99K | 0.02% | 705 |
|
|
2018
Q1 | $638K | Sell |
7,274
-1,436
| -16% | -$126K | 0.02% | 721 |
|
|
2017
Q4 | $754K | Hold |
8,710
| – | – | 0.02% | 684 |
|
|
2017
Q3 | $754K | Buy |
8,710
+6,923
| +387% | +$599K | 0.02% | 687 |
|
|
2017
Q2 | $138K | Sell |
1,787
-2,352
| -57% | -$182K | ﹤0.01% | 1118 |
|
|
2017
Q1 | $287K | Buy |
+4,139
| New | +$287K | 0.01% | 946 |
|